Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Pain 5Agnosia 4Pain, Postoperative 3Lung Neoplasms 3Colonic Neoplasms 2Cancer Pain 2Acute Pain 2Trigger Finger Disorder 1Thyroid Nodule 1Thyroid Neoplasms 1Thyroid Diseases 1Skin Neoplasms 1Rectal Neoplasms 1Patient Satisfaction 1Parathyroid Neoplasms 1Parathyroid Diseases 1Opioid-Related Disorders 1Neoplasms 1Multiple Myeloma 1Menorrhagia 1Median Neuropathy 1Leiomyoma 1Ileus 1Hemorrhage 1Head and Neck Neoplasms 1Goiter 1Ganglion Cysts 1Fever 1Emergence Delirium 1Diverticulosis, Colonic 1

Interventions

Sirolimus 3aldesleukin 2Tacrolimus 2Cyclosporine 2relatlimab 1oxycodone-acetaminophen 1abobotulinumtoxinA 1Vemurafenib 1Sodium Chloride 1Prednisone 1Nivolumab 1Mycophenolic Acid 1Meloxicam 1Ipilimumab 1Interleukins 1Interleukin-2 1Fluorouracil 1Everolimus 1Bleomycin 1Azathioprine 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Skin Neoplasms × Acetaminophen × Clear all
NCT07200544 2025-12-15

Meloxicam in Mohs Micrographic Surgery

University of Oklahoma

Phase 4 Recruiting
300 enrolled
Dermatologic

Pain, Postoperative, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡